Patent details
EP2068890 Title: USE OF ORITAVANCIN FOR PREVENTION AND TREATMENT OF ANTHRAX
Basic Information
- Publication number:
- EP2068890
- PCT Application Number:
- PCT/US/2007/079277
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP078727658
- PCT Publication Number:
- WO/2008/097364
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF ORITAVANCIN FOR PREVENTION AND TREATMENT OF ANTHRAX
- French Title of Invention:
- UTILISATION DE L'ORITAVANCINE POUR LA PRÉVENTION ET LE TRAITEMENT DE L'ANTHRAX
- German Title of Invention:
- VERWENDUNG VON ORITAVANCIN ZUR VORBEUGUNG UND BEHANDLUNG VON MILZBRAND
- SPC Number:
Dates
- Filing date:
- 24/09/2007
- Grant date:
- 08/01/2014
- EP Publication Date:
- 08/01/2014
- PCT Publication Date:
- 14/08/2008
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 17/06/2009
- EP B1 Publication Date:
- 08/01/2014
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 24/09/2014
- Expiration date:
- 24/09/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 24/09/2007
- Name:
- The Medicines Company
- Address:
- 8 Sylvan Way, Parsippany, NJ 07054, United States (US)
Inventor
1
- Name:
- MOECK Gregory
- Address:
- Canada (CA)
2
- Name:
- PARR Thomas, Reeves, Jr.
- Address:
- United States (US)
Priority
- Priority Number:
- 847397 P
- Priority Date:
- 25/09/2006
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/7052;
| Filing date | Document type | Number of pages |
|---|